BioHealth News
BHI’s EIR Ethel Rubin, Ph.D., Joins JLABS @ NYC Roundtable
Ethel Rubin, Ph.D., an Entrepreneur-in-Residence at BioHealth Innovation, Inc. (BHI), recently participated in a “CEO Roundtable” for JLABS @ NYC. The discussion revolved around…
Read MoreBHI EIR Renée JG Arnold Shares Expertise at the 28th Annual International ISPOR Meeting
Renée JG Arnold, PharmD, RPh, who serves as an Entrepreneur-in-Residence at BHI NHLBI EIR, recently moderated and participated in a panel discussion at the…
Read MoreWomen In Bio announces appointment of Gina Ford as Executive Director
Women In Bio is proud to announce that Gina Ford has joined our team as Executive Director. Gina brings a wealth of experience, having worked in…
Read MoreJoin AURP in Boston for a Deep Dive into Building Communities of “Biotech Innovation”!
Join AURP in Boston for a Deep Dive into Building Communities of Biotech Innovation! Before the 2023 BIO International Conference begins in Boston, the…
Read MoreNavigating the Challenges of Rare Disease Research with Dr. Harsha Rajasimha on BioTalk
Join us for an enlightening episode of BioTalk with Rich Bendis as we explore the pivotal role of patient registries in rare disease research…
Read MoreRaising Awareness: Indo US Bridging RARE Summit 2023 to Shine a Spotlight on Rare Diseases
Scheduled for October 29-30, 2023, at the George Mason University Campus in Arlington, VA, the Indo US Bridging RARE Summit 2023 aims to unite…
Read MoreRockville’s MaximBio Inks Contract with National Institutes of Health (RADx) Centered on a new Rapid Platform
ROCKVILLE, Md. , May 9, 2023 /PRNewswire/ -- MaximBio® is proud to announce it has signed a new agreement with the National Institutes of Health (NIH) through the Rapid Acceleration…
Read MoreTEDCO Announces Investment into Rise Therapeutics
Biotech company receives follow-on funding to accelerate ongoing clinical development efforts COLUMBIA, Md. (May 8, 2023) – TEDCO, Maryland’s economic engine for technology companies, announced a…
Read MoreMaxCyte Signs Strategic Platform License with Walking Fish Therapeutics to Support the Development of its Innovative B Cell Platform
Walking Fish to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to engineer novel B-cell based medicines for the treatment of serious diseases ROCKVILLE,…
Read MoreUS FDA approves GSK’s Arexvy, the world’s first respiratory syncytial virus (RSV) vaccine for older adults
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time The approval is based on…
Read MoreGain Therapeutics Awarded CHF 2.5 million Innosuisse Grant to Advance Lead Program in GBA1 Parkinson’s Disease
BETHESDA, Md., May 03, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX), a biotechnology company leading the discovery and development of allosteric small…
Read MoreQuest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio
Goal To Improve Patient Outcomes Through Early, Accurate Detection Of Residual Or Recurring Cancer Haystack’s Highly Sensitive Minimal-Residual Disease Cancer-Detection Technology To Be…
Read MoreDiscover the Future of Pediatric Healthcare: Register Now for the 2023 Children’s National Innovation Day & Showcase
Registration is Open for the 2023 Children’s National Innovation Day & Showcase Date: May 31, 2023 Time: 10:00 am - 7:00 pm Location: Children’s…
Read MoreVirginiabusiness.com: Betting on biotech, U.Va. institute may lead to research boom
Virginians have often sought experimental medical treatments outside the state — traveling to North Carolina, Boston or one of the Mayo Clinic’s locations. However,…
Read MoreBioTalk: Ensuring Quality and Compliance with Gaurav Walia – Mastering the Art of CSV in Life Sciences
Join us on an informative episode of BioTalk with Rich Bendis as we delve into the fascinating realm of computer systems validation (CSV)…
Read More